447 related articles for article (PubMed ID: 9625726)
1. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines.
Hecht SS
Chem Res Toxicol; 1998 Jun; 11(6):559-603. PubMed ID: 9625726
[No Abstract] [Full Text] [Related]
2. Tobacco-specific nitrosamines.
Hecht SS; Peterson LA; Spratt TE
IARC Sci Publ; 1994; (125):91-106. PubMed ID: 7806343
[No Abstract] [Full Text] [Related]
3. DNA adducts of nitrosamines.
Shuker DE; Bartsch H
IARC Sci Publ; 1994; (125):73-89. PubMed ID: 7806342
[No Abstract] [Full Text] [Related]
4. Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen.
Hecht SS
Crit Rev Toxicol; 1996; 26(2):163-81. PubMed ID: 8688159
[TBL] [Abstract][Full Text] [Related]
5. DNA and hemoglobin adducts as markers of metabolic activation of tobacco-specific carcinogens.
Foiles PG; Murphy SE; Peterson LA; Carmella SG; Hecht SS
Cancer Res; 1992 May; 52(9 Suppl):2698s-2701s. PubMed ID: 1563001
[TBL] [Abstract][Full Text] [Related]
6. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
[TBL] [Abstract][Full Text] [Related]
7. Progress and challenges in selected areas of tobacco carcinogenesis.
Hecht SS
Chem Res Toxicol; 2008 Jan; 21(1):160-71. PubMed ID: 18052103
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis for induction of human cancers by tobacco specific nitrosamines.
Nilsson R
Regul Toxicol Pharmacol; 2011 Jul; 60(2):268-80. PubMed ID: 21382430
[TBL] [Abstract][Full Text] [Related]
9. Effects of the Tobacco Carcinogens
Guttenplan JB; Chen KM; Sun YW; Shalaby NAE; Kosinska W; Desai D; Gowda K; Amin S; El-Bayoumy K
Chem Res Toxicol; 2019 Sep; 32(9):1893-1899. PubMed ID: 31433626
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of tobacco-specific N-nitrosamines and their metabolites and results of related bioassays.
Amin S; Desai D; Hecht SS; Hoffmann D
Crit Rev Toxicol; 1996; 26(2):139-47. PubMed ID: 8688157
[TBL] [Abstract][Full Text] [Related]
11. Approaches to the development of assays for interaction of tobacco-specific nitrosamines with haemoglobin and DNA.
Hecht SS; Carmella SG; Trushin N; Spratt TE; Foiles PG; Hoffmann D
IARC Sci Publ; 1988; (89):121-8. PubMed ID: 3198194
[TBL] [Abstract][Full Text] [Related]
12. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines.
Rivenson A; Hoffmann D; Prokopczyk B; Amin S; Hecht SS
Cancer Res; 1988 Dec; 48(23):6912-7. PubMed ID: 3180100
[TBL] [Abstract][Full Text] [Related]
13. Evidence for an important role of DNA pyridyloxobutylation in rat lung carcinogenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: effects of dose and phenethyl isothiocyanate.
Staretz ME; Foiles PG; Miglietta LM; Hecht SS
Cancer Res; 1997 Jan; 57(2):259-66. PubMed ID: 9000565
[TBL] [Abstract][Full Text] [Related]
14. Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone.
Hecht SS; Chen CB; Ohmori T; Hoffmann D
Cancer Res; 1980 Feb; 40(2):298-302. PubMed ID: 7356512
[TBL] [Abstract][Full Text] [Related]
15. Lung-specific expression of mutant p53 as mouse model for lung cancer.
Tchou-Wong KM; Rom WN
Methods Mol Med; 2003; 74():465-80. PubMed ID: 12415715
[No Abstract] [Full Text] [Related]
16. Metabolic activation and detoxification of tobacco-specific nitrosamines--a model for cancer prevention strategies.
Hecht SS
Drug Metab Rev; 1994; 26(1-2):373-90. PubMed ID: 8082576
[No Abstract] [Full Text] [Related]
17. HPV-16, tobacco-specific N-nitrosamine, and N-methyl-N'-nitro-N-nitrosoguanidine in oral carcinogenesis.
Kim MS; Shin KH; Baek JH; Cherrick HM; Park NH
Cancer Res; 1993 Oct; 53(20):4811-6. PubMed ID: 8402666
[TBL] [Abstract][Full Text] [Related]
18. 32P-postlabelling analysis of DNA-adducts formed by 4-(N-carbethoxy-N-nitrosamino)-(3-pyridyl)-1-butanone and 4-oxo-4-(3-pyridyl)- butanal.
Schmeiser HH; Castonguay A; Wiessler M
IARC Sci Publ; 1993; (124):207-10. PubMed ID: 8225486
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone for in vivo and iIn vitro murine embryopathy and embryonic ras mutations.
Winn LM; Kim PM; Wells PG
J Pharmacol Exp Ther; 1998 Dec; 287(3):1128-35. PubMed ID: 9864302
[TBL] [Abstract][Full Text] [Related]
20. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC.
Mirvish SS
Cancer Lett; 1995 Jun; 93(1):17-48. PubMed ID: 7600541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
